Canada markets close in 3 hours 12 minutes

CSPC Pharmaceutical Group Limited (CVG.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.7650-0.0464 (-5.72%)
At close: 08:02AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 9.19B
Enterprise Value 7.60B
Trailing P/E 12.00
Forward P/E 11.19
PEG Ratio (5 yr expected) 7.95
Price/Sales (ttm)2.24
Price/Book (mrq)2.13
Enterprise Value/Revenue 0.24
Enterprise Value/EBITDA 0.89

Trading Information

Stock Price History

Beta (5Y Monthly) 0.72
52-Week Change 3-13.27%
S&P500 52-Week Change 323.10%
52 Week High 30.9082
52 Week Low 30.6226
50-Day Moving Average 30.7198
200-Day Moving Average 30.7237

Share Statistics

Avg Vol (3 month) 32.79k
Avg Vol (10 day) 314.99k
Shares Outstanding 511.9B
Implied Shares Outstanding 612.02B
Float 88.26B
% Held by Insiders 129.79%
% Held by Institutions 132.08%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.03
Forward Annual Dividend Yield 44.30%
Trailing Annual Dividend Rate 30.25
Trailing Annual Dividend Yield 331.30%
5 Year Average Dividend Yield 42.19
Payout Ratio 446.38%
Dividend Date 3N/A
Ex-Dividend Date 4May 31, 2024
Last Split Factor 28:5
Last Split Date 3Oct 16, 2020

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 18.67%
Operating Margin (ttm)23.59%

Management Effectiveness

Return on Assets (ttm)9.96%
Return on Equity (ttm)18.22%

Income Statement

Revenue (ttm)31.45B
Revenue Per Share (ttm)2.65
Quarterly Revenue Growth (yoy)1.90%
Gross Profit (ttm)N/A
EBITDA 7.93B
Net Income Avi to Common (ttm)5.87B
Diluted EPS (ttm)0.0600
Quarterly Earnings Growth (yoy)-15.10%

Balance Sheet

Total Cash (mrq)13.76B
Total Cash Per Share (mrq)1.16
Total Debt (mrq)706.9M
Total Debt/Equity (mrq)2.02%
Current Ratio (mrq)2.63
Book Value Per Share (mrq)2.80

Cash Flow Statement

Operating Cash Flow (ttm)4.18B
Levered Free Cash Flow (ttm)1.16B